Contact information

Merck, Sharp & Dohme de España, SA (MSD)
Sara Cebrián Cuesta, Directora Asociada de Comunicación de MSD
Josefa Valcárcel, 38
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Vaccines
    • Therapeutic areas
      • Analgesia & Pain
      • Dermatology
      • Musculoskeletal system
      • Cardiovascular diseases and circulatory system
      • Infectious diseases
      • Inflammatory diseases
      • Gynaecology and obstetrics
      • Immunology
      • Ophtalmology and optometry
      • Oncology
      • Blood and lymphatic system
      • Digestive system and hepatology
      • Central nervous system
      • Respiratory and pulmonary system
      • Metabolic disorders / Endocrinology

Today's MSD is working to help the world be well. Through our medicines, vaccines, biologic therapies, and consumer and animal products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching programs that donate and deliver our products to the people who need them.

Corporate responsibility

Corporate responsibility is our daily commitment to save and improve lives by discovering better ways to make a difference in everything we do.

Products and services

MSD pipeline has over 20 promising late-stage candidates spanning the stages of life, and we have a presence in more than 100 countries around the world, including emerging markets. MSD also publishes unbiased health information as a non-profit service.

To visit MSD pipeline:

Areas of interest for future collaborations

Scientific discovery and development have always been the cornerstones of our company. Today, we conduct research in a broad range of therapeutic categories including cardiovascular disease, infectious diseases, vaccines, cancer, neurology and womens health. And, to help achieve our goal of saving and improving lives around the world, we are expanding our capabilities in new areas, such as biologics.